MIP-1-beta Antibody

(No reviews yet) Write a Review
SKU:
5249-100
£193.91
Frequently bought together:

Description

MIP-1-beta Antibodyis available at Gentaur for Next week Delivery.

Description: MIP-1β (macrophage inflammatory protein-1β) is a 69-amino acid CC chemokine with a molecular weight of 7.8 kDa. MIP-1β induces migration of monocytes/macrophages, and activates CD4+ cells, but not NK cells and eosinophils.

Immunogen Sequence:E. coli-expressed recombinant mature rat MIP-1β (a.a. 1-69)

Target Alternative Name:MIP-1, MIP1, MIP 1, MIP-1b, MIP 1b, MIP 1 beta, macrophge inhibitory protein-1 beta, macrophge inhibitory protein 1 beta, macrophge inhibitory protein

Species Reactivities:Mouse, rat

Tag Line:/

Formulation:100 µg (0.5 mg/ml) Protein A purified rabbit anti-rat MIP-1β polyclonal antibody in phosphate buffered saline (PBS), pH 7.2, containing 50% glycerol, 1% BSA, 0.02% sodium azide.

Purification: Affinity purified

Application:Western blot, Immunoprecipitation, Neutralization

Positive Control:/

Application And Usages:Western blot analysis (0.5-1 µg/ml), immunoprecipitation (4-8 µg/ml), and neutralization. However, the optimal conditions should be determined individually.

Handling:The antibody solution should be gently mixed before use.

View AllClose

Additional Information

Size:
100 µg
Antibody Target:
MIP-1b
Category:
MIP
Lot Number:
51049
Host:
Rabbit
Antibody Type:
Polyclonal
Isotype:
Rabbit IgG
Accession Number:
P50230
Gene Id:
116637
Concentration:
0.5 mg/ml
Appearance:
Colorless liquid
Form:
Liquid
Storage Condition:
-20 °C
Shipping Condition:
gel pack
Shelf Life:
12 months
Country of Animal Origin:
China
Country of Manufacture:
USA
Usage:
For Research Use Only! Not to be used in humans.
Western Blot Verified:
Verified
Immunocytochemistry Verified:
Not Verified
Immunofluorescence Verified:
Not Verified
Immunoprecipitation Verified:
Not Verified
FACS Verified:
Not Verified
ELISA Verified:
Not Verified
ChIP Verified:
Not Verified
Flow Cytometry Verified:
Not Verified
View AllClose

0 Reviews

View AllClose